Enrolling Now

Enrolling Now

Infusion Regimen for Type 1 Diabetes Stage 3

  • A study to investigate efficacy and safety of Infusion regimen compared with placebo in participants 16 to 25 years of age with Stage 3 Type 1 Diabetes.

    • Aged 16 to 25 years of age inclusive

    • Diagnosed with Type 1 Diabetes Stage 3 within 8 weeks

    Further qualifications apply: Must be positive for at least one Type 1 Diabetes autoantibody at screening

  • Gain access to cutting-edge medications and treatments before they are widely available.

    Our expert team is under the guidance of renowned endocrinologist, Dr. Anastasios Manessis.

    We are highly focused on patient well-being and the highest ethical standards in clinical research.

A yellow background with a measuring tape curled in a spiral, and several white pills scattered nearby.

Think you may qualify? Fill out this form and a member of our medical research team will be in touch shortly with more information.